TABLE 2.
Case | Plaque | Sex/Age | Disease Duration | Lipid Macrophages | AQP4-positive Astrocytes | GFAP-positive Astrocytes |
---|---|---|---|---|---|---|
11 | 11-1 | F 23 | 5 weeks | +++ | o | ± Present but rare |
12 | 12-1 | F 23 | 30 days/60 hoursa | +++ | o | ± Present but rare |
13 | 13-1 | F 27 | 32 months | +++ | o | o |
3 | 3-2 | M 25 | 29 days | ++ | ± | + |
3 | 3-3 | M 25 | 29 days | ++ | ± | +–++ |
14 | 14-1 | F 29 | 12 months | ++ | ± | +–++ |
13 | 13-2 | F 27 | 32 months | ++ | + | +–++ |
15 | 15-1 | F 27 | 49 months | ++ | + | + |
16 | 16-1 | M 34 | 3 years 11 months | ++ | + | +–++ |
17 | 17-1 | M 43 | 13 years | ++ | + | +–++ |
15 | 15-2 | F 27 | 49 months | ± | ++ | ++ |
10 | 10-2 | M 36 | 3 years | ± | ++ | ++ |
18 | 18-1 | M 55 | “Long standing” | ± | ++ | ++ |
18 | 18-2 | M55 | “Long standing” | ± | ++ | ++ |
Cell counts in demyelinated edge zones: o, none; ±, few or none; +, small numbers; ++, moderate numbers; +++, large numbers. Case 12, the third patient in the present study with fatal neurogenic pulmonary edema, died 60 hours after the onset of a third relapse. No corticosteroids or other immunosuppressive medication received.